Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TCS Named a Leader and Star Performer in Life Sciences Operations by Everest Group

Posted On: 2020-02-14 16:53:30


Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been named a Leader and Star Performer in the Everest Group PEAK Matrix® for Life Sciences (LS) Operations.

In an assessment of 24 global life sciences service providers, TCS was positioned highest for Vision and Capability. Cited as a strength is TCS' significant scale in the LS operations services market, with solutions like its cloud-based TCS ADD platforms witnessing increased traction in the market, particularly the TCS Connected Clinical Trials™ platform, which enables patient engagement and clinical supply process visibility. The report highlights that TCS is deploying automation for multiple customers in pharmacovigilance, data management, and the medical affairs segments, which is augmented by its in-house technology engine - the TCS Decision Fabric.

TCS was positioned as a Star Performer for its addition of new customers in the clinical trials and regulatory affairs value chain segments, and investments in building solutions and its talent pool to expand into newer processes such as commercial operations and supply chain.

"Life sciences enterprises are leveraging emerging technologies and next-gen platforms to overcome the challenges that come with rising costs, declining revenues, data explosion, continued M&A pursuits, and increasingly complex regulations, as well as to drive digitization in R&D and focus on specialty drugs," said Debashis Ghosh, Business Group Head, Life Sciences and Healthcare, TCS. "This leadership position is a validation of our vision and strategy, global scale, portfolio of domain-focused platform solutions, and the resultant market impact."

TCS collaborates with leading life sciences companies to enable their digital transformation journey by leveraging its Business 4.0™ framework and Machine First™ Delivery Model (MFDM™). TCS offers a full set of business operations and transformation services and solutions including advisory services, predictive and prescriptive analytics, clinical operations, regulatory services, laboratory platforms, AI / ML solutions, pharmacovigilance, genomics research, blockchain, and medical articles and medico marketing. Early investments in re-skilling the workforce, building agile workplaces, and developing intellectual property have helped TCS gain significant scale and depth in digital technologies.

The company's extensive portfolio of intellectual property - including the award winning TCS ADD platform suite, Real World Evidence platform, Decision Fabric™ engine, TCS Connected Clinical Trials™ platform and Translational Research Platform - help customers achieve better speed to market and superior business outcomes.

"The life sciences industry is under tremendous pressure to streamline processes, comply with regulatory norms, launch newer drugs at a faster pace, and deliver real value for patients. Under the weight of such issues, the core capability of a pharma company - innovation - can often take a back seat," says Manu Aggarwal, Vice President, Everest Group. "TCS' investments in creating an integrated platform - the Advanced Drug Development (TCS ADD) platform - along with focus on building deep domain expertise and expansion into newer services such as commercialization is bringing the focus back on drug innovation."

"Our focus on innovation, technology-driven solutions and platforms that digitize the life sciences value chain, contextual knowledge, as well as significant investments in innovation labs and upskilling of digital talent, position us as a preferred partner to drive our customers' growth and transformation agendas," added Debashis Ghosh.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.2183.8 as compared to the previous close of Rs. 2191.6. The total number of shares traded during the day was 58034 in over 4579 trades.

The stock hit an intraday high of Rs. 2211.55 and intraday low of 2170.95. The net turnover during the day was Rs. 127121733.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Sonata Launches 'CSK 2020 Edition' for Chennai Superkings Fans

Universal Cables Ltd updates on capacity expansion

Innovators Facade Systems Limited receives work order of Rs. 26 crores

MRPL shareholders approve proposal to raise funds of Rs. 5000 crore

ITC Ltd increases stake in Delectable Technologies Pvt Ltd

PNB associate bank, JSC Tengri Bank's License revoked

ITC Ltd.'s Sunfeast YiPPee!'s 10th Anniversary celebrations make a GUINNESS WORLD RECORDS® achievement

RITES Ltd board approves buy back through tender offer at Rs. 265

Route Mobile Limited shares to list on Monday - Sep 21, 2020

Mysore Petro Chemicals Limited to write-off GBP 770,000

Somany Ceramics adds a dash of style at T2, Mumbai Airport.

United Spirits Ltd announces resignation of CFO

Lords Chloro Alkali Ltd posts loss of Rs. 1.08 crore in Q1FY21

Zydus Cadila receives final approval from USFDA for Potassium Chloride Extended-Release Tablets

ICRA upgrades rating of Escorts Ltd

Bhatia Mobile to Migrate to main board of BSE

Avantel Ltd receives order of Rs. 15.97 crore from Bharat Electronics Ltd

Magna Electro Castings Ltd board approves buy back at Rs. 175

TATA Tea Chakra Gold Becomes Official Tea Partner for Chennai Super Kings in IPL 2020

Tiger Logistics India Limited provides future Business Outlook

Dr. Reddy's Laboratories announces settlement of U.S. Revlimid® Capsules patent litigation with Celgene

TVS Motor Company expands and strengthens its presence in Colombia

ICICI Securities successfully closes ~INR 6,000 mm IPO of Route Mobile Limited

EIH Limited approves rights issue, fixes Sep 23, 2020 as record date

Hindalco and Hindustan Copper sign MoU for supply of copper concentrate

Kilpest India Limited to merge subsidiary with itself, change name as 3B BlackBio Dx Ltd

Sterling and Wilson Solar Limited Signs order of 106.71 MW worth USD 62.6 mn in Chile

South Korea donates One lakh masks to TVS Motor Company for free distribution to aid India's fight against COVID-19

TCS Recognized as a Leader in Cloud-Native Application Development Services by Everest Group

Power Grid Corporation of India Ltd receives approval for setting up of InvIT

Mahindra Happinest® sells 100+ homes online within a week at 'Happinest Palghar'

Ramco Systems signs agreement with Arla Foods

IRCON International Ltd secures order worth Rs. 1900 crore

Phoenix Group Partners with TCS to Introduce Enhanced Analytics for Workplace Pension Clients

L&T Construction secures order from Northern Coalfields Ltd

Dr. Reddy's announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market

Ashok Leyland receives an order for 1400 ICVs from Procure Box

PTC India Financial Services Ltd receives Rs. 115.57 crore IT refund

Thomas Cook India & SOTC partner with India's favourite storyteller Amar Chitra Katha

Shankar Lal Rampal Dye-Chem Ltd Board to consider Bonus Issue of Equity Shares

Dhanuka Agritech Ltd fixes Sep 28, 2020 as record date for buy-back

Sterling and Wilson Solar Limited declares financial results for quarter ending 30th June 2020

JMC secures new orders of Rs. 1,342 Crores

ABM Knowledgeware Ltd bags Rs 127.44 Crores order for SAP Technology Modernization

Titan Company with SBI launches India's first contactless payment watches

Bajaj Consumer Care Joins hand with IndiaMART, to enhance their digital presence in B2B market segment

ICICI Securities successfully closes ~INR 7,020 mm IPO of Happiest Minds Technologies Limited

The Bank of Bahrain and Kuwait goes live with iGTB's Contextual Digital Transaction Banking platform to support growth

HCL and Google Cloud Expand Partnership to Deliver Accelerated Business Intelligence Platform

CARE Ratings reaffirms 'CARE A-' rating with stable outlook for Jindal Stainless (Hisar) Limited







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019